India's pharmaceutical companies are gearing up to become a major global player, not only in producing low-price generic medicines but also as innovators in drugs and vaccines, according to a study.
India could revolutionise biotechnology on the basis of its large and increasingly well-educated workforce, just as it did information technology, Singer believes.
The costs are considerably lo ... Read More

Pharmaceutical sales in the U.S. will drop to a third of global sales in 2008, from a 50 percent share two years ago, a report released Thursday says.
Prescription drugs sales in emerging economies in China, Brazil, Turkey, Mexico and elsewhere are booming but the gains will be offset by the loss of patent protection for profitable drugs worth $20 billion in annual sales in 2008, predicts heal ... Read More

FDA is expected to unveil a new voucher program that will reward drug companies for research into neglected diseases by accelerating drug reviews, the Financial Times reports.
The "priority review vouchers" will grant drug companies a six-month review period if they receive FDA approval for drugs to treat certain diseases, such as malaria and tuberculosis. These reviews usually take between 10 ... Read More